The LATTE study: a provocative brew

Lancet Infect Dis. 2015 Oct;15(10):1116-1117. doi: 10.1016/S1473-3099(15)00224-8. Epub 2015 Jul 19.

Authors

Mark Alastair Boyd¹, David A Cooper²

Affiliations

¹ The Kirby Institute for Infection and Immunity in Society, UNSW Australia, Sydney, NSW 2052, Australia. Electronic address: mboyd@kirby.unsw.edu.au.
² The Kirby Institute for Infection and Immunity in Society, UNSW Australia, Sydney, NSW 2052, Australia.

PMID: 26201302
DOI: 10.1016/S1473-3099(15)00224-8

No abstract available

Publication types

Comment

MeSH terms

Anti-Retroviral Agents / administration & dosage*
Antiretroviral Therapy, Highly Active / methods*
Female
HIV Infections / drug therapy*
Humans
Male
Pyridones / administration & dosage*
Reverse Transcriptase Inhibitors / administration & dosage*
Rilpivirine / administration & dosage*

Substances

Anti-Retroviral Agents
Pyridones
Reverse Transcriptase Inhibitors
Rilpivirine